Wednesday, October 15, 2025

4:00 PM - 5:30 PM

---

Details

Recent investment in hepatitis C prevention implementation trials in low- and middle-income countries have brought to the fore participatory and community-led research methods designed to deliver harm reduction programs that deliver low dead-space needles and syringes and reflect the values and preferences of people who inject drugs. These activities have accelerated discussions on new ways to approach the procurement and deployment of optimised harm reduction commodities to enhance local NSP coverage and the global NSP impact. This session aims to conceive a paradigm-shifting and practical blueprint for NSP commodity procurement that translates community research practices and outcomes generated in the current Unitaid hepatitis C prevention portfolio. The session will explore the potential for pragmatic tools to help donor recipients make community-informed decisions when requesting and procuring NSP commodities that are effective at reducing injecting-related risks and harms. In the context of updated practical guidance from the WHO for establishing and maintaining NSPs, we will explore how pragmatic practices can catalyse a new era of global harm reduction that places the needs of people who inject drugs at its centre.

---

Speaker